摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5R,5aR,8aS,9S)-9-((2,2-difluoro-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)ethyl)amino)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one | 1616619-26-1

中文名称
——
中文别名
——
英文名称
(5R,5aR,8aS,9S)-9-((2,2-difluoro-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)ethyl)amino)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one
英文别名
Adva-27afh;(5S,5aS,8aR,9R)-5-[[2,2-difluoro-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethyl]amino]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
(5R,5aR,8aS,9S)-9-((2,2-difluoro-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)ethyl)amino)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one化学式
CAS
1616619-26-1
化学式
C29H33F2NO12
mdl
——
分子量
625.577
InChiKey
PUNLTGSKFRGUDP-RPNBGQTISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    826.2±65.0 °C(Predicted)
  • 密度:
    1.60±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    44
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    186
  • 氢给体数:
    6
  • 氢受体数:
    15

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS AS ANTI-CANCER AGENTS
    申请人:ADVANOMICS CORPORATION
    公开号:US20150353573A1
    公开(公告)日:2015-12-10
    The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
    本文描述了一类由鬼臼毒素衍生的双氟基C-糖苷化合物的合成,这些化合物可以用于肿瘤学领域的癌症治疗,但不仅限于此。更具体地说,鬼臼毒素双氟基C-糖苷共轭衍生物显示出改善的构象和化学稳定性,并对耐药癌细胞系表现出改善的细胞毒性。
  • PROCESS FOR PREPARING GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS
    申请人:Advanomics Corp.
    公开号:EP3530663A1
    公开(公告)日:2019-08-28
    The present invention concerns the synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin which may be used, but not exclusively, in oncology for the treatment of cancer.
    本发明涉及一类由荚叶肿毒素衍生的宝石-二氟化 C-糖苷化合物的合成,该化合物可用于(但不限于)肿瘤学中的癌症治疗。
  • Gem-difluorinated C-glycoside compounds as anti-cancer agents
    申请人:ADVANOMICS CORPORATION
    公开号:US10272065B2
    公开(公告)日:2019-04-30
    The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
    本文件介绍了一类由荚叶肿毒素衍生的二氟化C-糖苷化合物的合成,该化合物可用于(但不限于)肿瘤学中的癌症治疗。更特别的是,荚叶素二氟化 C-糖苷衍生物具有更好的构象和化学稳定性,对耐药性癌细胞株的细胞毒性也有所提高。
  • [EN] GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS AS ANTI-CANCER AGENTS<br/>[FR] COMPOSÉS C-GLYCOSIDES GEM-DIFLUORÉS EN TANT QU'AGENTS ANTICANCÉREUX
    申请人:ADVANOMICS CORP
    公开号:WO2014107803A1
    公开(公告)日:2014-07-17
    The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
    本文描述了一类由鬼臼毒素衍生的宝石二氟基C-糖苷化合物的合成,这些化合物可以用于肿瘤学治疗,但不仅限于此。更具体地说,鬼臼毒素宝石二氟基C-糖苷化衍生物显示出改善的构象和化学稳定性,并且对耐药癌细胞系表现出改善的细胞毒性。
查看更多

同类化合物

鹅掌楸碱 罗汉松树脂酚-4'-O-β-龙胆二糖苷 络石苷元-4'-O-BETA-龙胆二糖苷 络石苷 牛蒡苷 柑属苷B 松脂醇二葡萄糖苷 松脂醇-4-O-beta-D-吡喃葡萄糖苷 松脂醇 beta-D-吡喃葡萄糖苷 木須皮苷 异落叶松脂素-9'-O-beta-D-吡喃葡萄糖苷 开环异落叶松脂素BETA-D-葡糖苷 地菲林葡萄糖苷 南烛木糖甙 刺五加苷D 刺五加甙E 刺五加甙 E 刺五加提取物 丁香树脂醇双葡萄糖苷 b-D-吡喃葡萄糖苷,4-[(1R,2R)-1,3-二羟基-2-[4-[(1E)-3-羟基-1-丙烯-1-基]-2-甲氧基苯氧基]丙基]-2-甲氧苯基 Ssioriside; (2S,3S)-4-羟基-2,3-双[(4-羟基-3,5-二甲氧基苯基)甲基]丁基 beta-D-吡喃木糖苷 8-羟基松脂醇二葡萄糖苷 8-O-(α-阿拉伯呋喃糖)-β-àpeltatin 4-(1,3-苯并二氧戊环-5-基)-9-[(2S,3R,4S,5R)-3,4-二甲氧基-5-[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基四氢吡喃-2-基]氧基-6,7-二甲氧基-1H-苯并[f][2]苯并呋喃-3-酮 4-(1,3-苯并二氧戊环-5-基)-6,7-二甲氧基-9-[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-1H-苯并[f][2]苯并呋喃-3-酮 3-[2,3-二氢-6-羟基-2-(1-羟基-1-甲基乙基)苯并呋喃-5-基]-8-(beta-D-吡喃葡萄糖基)-2,3-二氢-5,7-二羟基-4H-1-苯并吡喃-4-酮 2,3-双(3-甲氧基-4-羟基苄基)丁烷-1,4-二醇 1,4-二葡萄糖甙 (3S,4R)-4-(苯并[1,3]二氧杂环戊烯-5-基甲基)-3-[(S)-[(2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-(3,4,5-三甲氧基苯基)甲基]四氢呋喃-2-酮 (3R,4S)-3-[[4-(beta-D-吡喃葡萄糖基氧基)-3-甲氧基苯基]甲基]-4,5-二氢-4-[(4-羟基-3-甲氧基苯基)甲基]呋喃-2(3H)-酮 (-)-异落叶松脂素-9'-O-BETA-D-吡喃葡萄糖苷 (+)-南烛木树脂酚9'-O-葡萄糖甙 4-O-[2"-O-[6-[4-hydroxypiperidin-1-yl]hexyl]-3",4"-di-O-methyl-β-D-xylopyranosyl]diphyllin 4-O-[2"-O-[8-[4-hydroxypiperidin-1-yl]octyl]-3",4"-di-O-methyl-β-D-xylopyranosyl]diphyllin phyllanthusmin B (2S,3R,4S,5S)-2-((9-(benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxy-1,3-dihydronaphtho[2,3-c]furan-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (2S,3R,4S,5S)-2-((9-(benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxy-3-oxo-1,3-dihydronaphtho[2,3-c]furan-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate tri-O-acetylpatentiflorin A phyllanthusmin D 2")-β-D-xylopyranosyl-(1""->5")-β-D-apiofuranosyl]diphyllin">4-O-[α-L-arabinopyranosyl-(1"'->2")-β-D-xylopyranosyl-(1""->5")-β-D-apiofuranosyl]diphyllin (+)-syringaresinol 4-O-β-D-glucopyranosyl(1->6)-β-D-glucopyranoside liriodendrin 4-O-[6-O-(5-O-sinapoyl-β-D-apiofuranosyl)-β-D-glucopyranosyl]-(+)-(7S,7'S,8R,8'R)-4'-hydroxy-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane 4-O-[3″,4″-di-O-methyl-β-d-xylopyranosyl]diphyllin (+)-medioresinol di-O-β-D-glucopyranoside (-)-(8S,8'R)-4,4'-dihydroxy-3,3',5'-trimethoxylignan-4'-O-β-D-glucopyranoside (-)-nectandrin B-β-D-glucopyranoside (3S)-4''-O-β-D-Glucopyranosylhinokiresinol 4'-O-β-D-glucopyranosylhinokiresinol (7R,8R)-4,7,9,3′,9′-pentahydroxy-3-methoxy-8,4′-oxyneolignan-3′-O-β-D-glucopyranoside (7S,7'R,8R,8'S)-7'-butoxy-7,9'-epoxy-4,4',9-trihydroxy-3,3'-dimethoxylignane 9-O-β-D-glucopyranoside